Committee for Medicinal Products for Human Use

Committee for Medicinal Products for Human Use latest

July 25th, 2009 - 09:26 GMT

Sanofi-aventis welcomes the European Medicines Agency’s statement on Lantus® safety

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that following the review of the available evidence on Lantus® (insulin glargine [rDNA] i

July 22nd, 2009 - 02:55 GMT

ISENTRESS® (raltegravir), from MSD, was as Effective as Efavirenz at

May 17th, 2009 - 07:18 GMT

Targeted therapy agent for lung cancer to be introduced in UAE soon

May 8th, 2006 - 08:07 GMT

Committee for Medicinal Products for Human Use latest

Sanofi-aventis welcomes the European Medicines Agency’s statement on Lantus® safety

ISENTRESS® (raltegravir), from MSD, was as Effective as Efavirenz at

Targeted therapy agent for lung cancer to be introduced in UAE soon

ACOMPLIA® (for obesity and associated risk) RECOMMENDED FOR APPROVAL IN THE EUROPEAN UNION